All News

Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.

Jennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.

In a post hoc secondary analysis of the BP-CATCH trial, researchers explored the best ways of screening children with high blood pressure and managing their care.

Adolescent obesity rates have risen in recent years, and a number of treatment options can be taken to help reduce the risk of a variety of associated medical problems.

A recent systematic review and meta-analysis found that almost half of all patients with type 2 diabetes were deficient in multiple micronutrients.

Natalie DiPietro Mager, PharmD, PhD, discusses the role of community pharmacy in maternal health.

Scott Nelson, PharmD, MS, FAMIA, ACHIP, discussed the increasingly crucial role artificial intelligence has played in streamlining pharmacy services.

Researchers analyzed liveborn infant data from January 2020 to June 2024 to determine prevalence, cause, and treatment strategies for pain among preterm infants.

Ozempic is now the most broadly indicated glucagon-like peptide-1 receptor agonist across the pharmaceutical drug market.

Researchers conducted a literature review of patients’ clinical experiences with using secukinumab to treat psoriatic arthritis.

Researchers analyzed overall prescription stimulant dispensing trends among US children from 2017 to 2023.

A discussion with Natalie DiPietro Mager, PharmD, PhD, on how community pharmacists can improve access to contraceptive services.

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, sat down with Drug Topics to discuss challenges within the business behind health-system pharmacies.

Among a population of patients with type 2 diabetes, researchers assessed the similarities and differences between SGLT2 inhibitors.

Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University, provides best tips and practices for providing maternity care.

Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.

Jonathan Watanabe, PharmD, MS, PhD, BCGP, joined Drug Topics to discuss how pharmacists can facilitate improved patient outcomes through collaborative care.

Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.

The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.

A discussion with Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University.

To highlight the effectiveness of pediatric obesity treatment, researchers measured its impact on morbidity and mortality in young adulthood.

Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.

The US government is entrusting mRNA vaccine pioneers Moderna to develop protection for the gradually increasing threat of avian influenza.

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

Kurt Proctor, PhD, RPh, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.

For adults with obesity but no diabetes diagnosis, researchers searched for the key factors leading to semaglutide initiation.

The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.

Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed a section of the ASHP 2025 Pharmacy Forecast that he co-authored titled “Addressing the Gap in Primary Care.”